Search research articles
Contact Us
Filters
Showing results (1-10 of 142) with videos related to
Page
of 15
Sort By:
Cancer Journal (Sudbury, Mass.)
|
November 18, 2000
Molecular diagnosis of pancreatic and biliary cancer: ready for broad implementation?
J L Abbruzzese
Seminars in Oncology
|
October 1, 1996
Phase I studies with the novel nucleoside analog gemcitabine
J L Abbruzzese
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Studies on the mechanism of the synergistic interaction between 2'-deoxy-5-azacytidine and cisplatin
J L Abbruzzese, P Frost
Hematology/Oncology Clinics of North America
|
March 1, 1989
Treatment of advanced colorectal cancer
J L Abbruzzese, B Levin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2001
Matrix metalloproteinase inhibition of pancreatic cancer: matching mechanism of action to clinical trial design
K R Hess, J L Abbruzzese
Neurology
|
February 1, 1992
Cognitive functioning in cancer patients: effect of previous treatment
C A Meyers, J L Abbruzzese
Hospital Practice (Office Ed.)
|
December 15, 1991
Adenocarcinoma of the liver without a detectable primary
J L Abbruzzese, P P Carbone
The Johns Hopkins Medical Journal
|
March 1, 1981
Postural hypotension
J L Abbruzzese, J W Griffin
Annals of Surgical Oncology
|
February 25, 1999
Chemoradiation for localized pancreatic cancer: another perspective
D B Evans, J L Abbruzzese
Cancer Research
|
April 15, 1992
Synergistic cytotoxicity with 2'-deoxy-5-azacytidine and topotecan in vitro and in vivo
H Anzai, P Frost, J L Abbruzzese
Page
of 15
Search research articles
Search
Showing results (1-10 of 142) with videos related to
Sort By:
Page
of 15
Cancer Journal (Sudbury, Mass.)
|
November 18, 2000
Molecular diagnosis of pancreatic and biliary cancer: ready for broad implementation?
J L Abbruzzese
Seminars in Oncology
|
October 1, 1996
Phase I studies with the novel nucleoside analog gemcitabine
J L Abbruzzese
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Studies on the mechanism of the synergistic interaction between 2'-deoxy-5-azacytidine and cisplatin
J L Abbruzzese, P Frost
Hematology/Oncology Clinics of North America
|
March 1, 1989
Treatment of advanced colorectal cancer
J L Abbruzzese, B Levin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2001
Matrix metalloproteinase inhibition of pancreatic cancer: matching mechanism of action to clinical trial design
K R Hess, J L Abbruzzese
Neurology
|
February 1, 1992
Cognitive functioning in cancer patients: effect of previous treatment
C A Meyers, J L Abbruzzese
Hospital Practice (Office Ed.)
|
December 15, 1991
Adenocarcinoma of the liver without a detectable primary
J L Abbruzzese, P P Carbone
The Johns Hopkins Medical Journal
|
March 1, 1981
Postural hypotension
J L Abbruzzese, J W Griffin
Annals of Surgical Oncology
|
February 25, 1999
Chemoradiation for localized pancreatic cancer: another perspective
D B Evans, J L Abbruzzese
Cancer Research
|
April 15, 1992
Synergistic cytotoxicity with 2'-deoxy-5-azacytidine and topotecan in vitro and in vivo
H Anzai, P Frost, J L Abbruzzese
Page
of 15